Impact of ERβ and CD44 expression on the prognosis of patients with stage II colon cancer.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Volumn 33, Issue 6, 2012, Pages 1907-1914

  Fang, Yu Jing ^a   Zhang, Lin ^b   Wu, Xiao Jun ^b   Lu, Zhen Hai ^b   Li, Ji Bin ^b   Ou, Qing Jian ^b   Zhang, Mei Fang ^b   Ding, Pei Rong ^b   Pan, Zhi Zhong ^b   Wan, De Sen ^b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD44 PROTEIN, HUMAN; ESTROGEN RECEPTOR BETA; HERMES ANTIGEN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CHILD; COLON; COLON TUMOR; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; TISSUE MICROARRAY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; CHILD; COLON; COLONIC NEOPLASMS; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 85027953046     PISSN: None     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-012-0451-y     Document Type: Article

References (0)